Professor Brendan Crabb AC
Professor Brendan Crabb AC is the Director and CEO of Burnet Institute and immediate Past President of AAMRI. Professor Crabb is a molecular biologist with a particular interest in infectious diseases and in health issues of the developing world. His personal research focus is on the development of a malaria vaccine and the identification of new treatments for this disease.
Professor Crabb is also Chairman of Alfred Medical Research and Education Precinct (AMREP) Council and Chairman of the PATH/Malaria Vaccine Initiative Science Portfolio Advisory Committee in the US. Professor Crabb holds Professorial appointments at The University of Melbourne and Monash Universities. Until his appointment as Director of the Burnet Institute he was a Senior Principal Research Fellow of the National Health & Medical Research Council of Australia, and an International Research Fellow of the US-based Howard Hughes Medical Institute.
He serves on the Scientific Advisory Boards of the UK-based Sanger Institute’s Malaria Program and the Monash Institute of Pharmaceutical Science. Professor Crabb was the Editor-in-Chief of the world’s leading parasitology research journal the International Journal for Parasitology from 2006 to 2009 and remains on its editorial board along with that of Nature Communications, Eukaryotic Cell and F1000 Reports.
Professor Crabb has a strong interest in education. He was formerly a Senior Lecturer in the Department of Microbiology and Immunology at The University of Melbourne and is currently involved in bringing modern bioscience to primary and secondary school students and teachers through a long-term role on the board of the Gene Technology Access Centre in Melbourne.